Crush­ing their cat­e­gories? Physi­cians weigh in on phar­ma com­pa­nies by ther­a­py area

Phar­ma com­pa­nies tend to fo­cus on spe­cif­ic ther­a­py ar­eas, but does spe­cial­iz­ing equate to pos­i­tive cat­e­go­ry per­cep­tions with physi­cians? Gen­er­al­ly, the an­swer is yes, ac­cord­ing to a re­cent Zoom­Rx sur­vey among spe­cial­ists.

Ab­b­Vie, for ex­am­ple, dom­i­nat­ed im­munol­o­gy, with an over­all 79% of doc­tors rank­ing it among the top three lead­ers in the field. Pfiz­er, Sanofi, Janssen and Am­gen fell in be­hind, al­though pret­ty far back, with per­cent­ages rang­ing in the 30s.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.